Clinical Trial

Effects of TNF Blockade on Human BPH/LUTS

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Specific Aim 1. To evaluate the efficacy of TNF antagonist action in BPH/LUTS Specific Aim 2. Define the consequences of TNF antagonist therapy on prostate tissue Specific Aim 3. Identify genetic predictors to stratify patients with differential response to TNF-antagonist therapy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-09-25; most recent amendment 2024-11-18.
Status change: Not Yet Recruiting → Recruiting 2024-04-19
Trial Details
NCT Number NCT06062875
Lead Sponsor Endeavor Health
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Benign Prostatic Hyperplasia (BPH)
Enrollment 70 participants
Start Date 2024-01-24
Primary Completion 2028-04-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2024-11-21